Fulgent Genetics, Inc. has 5 Schedule 13D or 13G filings on record since 2025-07-29. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Ming Hsieh | 32.26% | 8,872,539 | SCHEDULE 13D/A, 2026-05-27 | 2026-05-22 |
| Integrated Core Strategies (US) LLC | 3% | 918,503 | SCHEDULE 13G/A, 2026-02-04 | 2025-12-31 |
Purpose of Transaction (Item 4)
Ming Hsieh
The Reporting Person holds the shares of Common Stock reported in this Statement for general investment purposes. The Reporting Person may, from time to time, acquire additional, or dispose of, shares of Common Stock or other securities of the Issuer, in the Reporting Person's capacity as Chief Executive Officer and Chairperson of the Board of the Issuer or otherwise, or engage in discussions with the Issuer concerning investments in the Issuer. The Reporting Person intends to review his ownership of Common Stock (including shares of Common Stock held through the Trust) on a continuing basis and, depending upon the price and availability of shares of Common Stock of the Issuer, subsequent developments affecting the Issuer, the Issuer's business and prospects, other investment and business opportunities available to the Reporting Person, general stock market and economic conditions, tax considerations and other factors considered relevant, the Reporting Person may decide at any time to increase or to decrease the size of his holdings of the Issuer's securities or securities derived of, exercisable for or convertible into the Issuer's securities.Item 4 of the SCHEDULE 13D/A filed 2026-05-27
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-29 | Millennium Management LLC | 4.7% | SCHEDULE 13G/A |
| 2025-07-29 | Millennium Management LLC | 5.6% | SCHEDULE 13G/A |
| 2026-02-04 | Integrated Core Strategies (US) LLC | 3% | SCHEDULE 13G/A |
| 2026-03-31 | Ming Hsieh | 30.74% | SCHEDULE 13D/A |
| 2026-05-27 | Ming Hsieh | 32.26% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Fulgent Genetics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.